Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Haitian Xinheng Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-quality pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Headquartered in Hefei, Anhui Province, the company operates advanced production facilities that comply with international quality standards to support the global pharmaceutical supply chain. Their core product offerings include intermediates for widely used medications in the cardiovascular, respiratory, and anti-infective therapeutic categories, such as statins and leukotriene receptor antagonists. In addition to its standard product catalog, Haitian Xinheng provides custom synthesis and contract manufacturing (CMO) services tailored to the specific needs of pharmaceutical innovators and generic manufacturers. The company is recognized for its technical expertise in complex chemical synthesis and its commitment to reliable large-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Haitian Xinheng Pharmaceutical.